logo

MDXH

MDxHealth·NASDAQ
--
--(--)
--
--(--)
2.05 / 10
Underperform

Comprehensive review: 2.0/10 score signifies subpar fundamentals. Optimistic factors: Profit-MV and Cash-MV, despite concerns regarding Revenue-MV and PB-ROE. Resulting view: guarded.

Fundamental(2.05)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.26
Score1/3
Weight12.86%
1M Return5.20%
Inventory turnover ratio
Value5.50
Score3/3
Weight11.30%
1M Return5.26%
Gross profit margin (%)
Value65.04
Score2/3
Weight3.18%
1M Return1.47%
Profit-MV
Value0.46
Score2/3
Weight19.25%
1M Return7.79%
PB-ROE
Value1.24
Score0/3
Weight8.79%
1M Return3.56%
Current assets turnover ratio
Value1.25
Score1/3
Weight-0.97%
1M Return-0.48%
Fixed assets turnover ratio
Value16.00
Score2/3
Weight0.25%
1M Return0.12%
Asset-MV
Value-0.50
Score1/3
Weight23.34%
1M Return8.74%
Cash-MV
Value-0.07
Score2/3
Weight19.28%
1M Return7.73%
Net profit / Total profit (%)
Value98.85
Score2/3
Weight2.72%
1M Return1.28%
Is MDXH undervalued or overvalued?
  • MDXH scores 2.05/10 on fundamentals and holds a Premium valuation at present. Backed by its -747.67% ROE, -30.50% net margin, -5.77 P/E ratio, -21.94 P/B ratio, and 66.01% earnings growth, these metrics solidify its Underperform investment rating.